Only one study has preliminarily demonstrated using immunohistochemistry that GAD1 is highly specific and sensitive in benign and malignant prostate tissues [37].Thus, GAD1 is a promising candidate for the exploration of prostate cancer. Here, GAD1 is linked to prostate carcinoma.